James Reynolds
Showing 1–3 of 3 transcripts.
- Milken Institute1h 3m
Credit Outlook | Global Conference 2025
Michael Milken, Lee Kruter, Drew McKnight, Purnima Puri, James Reynolds, Christian Stracke
Driven by the 2023 banking retrenchment and rising institutional demand for yield, major asset managers including PIMCO, Fortress, and Goldman Sachs are shifting capital from traditional lending to non-investment-grade private credit and alternative financing structures. Panelists identify significant growth opportunities in undervalued asset-based credit, data center infrastructure, and expanding markets in Europe, Latin America, and the Middle East, while emphasizing defensive strategies focused on recovery rates rather than default probabilities. Despite regulatory uncertainties and untested default cycles, experts project the sector will scale significantly to fill the void left by contracting bank balance sheets.
- Goldman Sachs20 min
The case for private credit
James Reynolds, Lotfi Karoui, Alison Nathan
With private credit assets expanding to $2.1 trillion, the sector has evolved into a dominant financing alternative for private equity and sub-investment-grade borrowers, driven by institutional investors seeking inflation hedges and floating-rate yields. Despite limited historical recession data, the industry demonstrates resilience through superior creditor coordination and regulatory leverage caps that mitigate systemic fragility compared to the pre-2008 banking system. Looking forward, senior direct lending and flexible capital solutions in Europe and the U.S. present primary growth areas as traditional bank underwriting retreats, while emerging distressed opportunities in cyclical sectors offer avenues for debt-to-equity restructuring.
- Milken Institute1h 0m
Private Credit Cashing In | Milken Institute Global Conference 2024
Liz Hoffman, Dianna Carr-Coletta, David Geenberg, Theodore L. Koenig, Danielle Poli, James Reynolds, Ted, Francois Chollette
Private credit assets have expanded to an estimated $1.5 trillion through a 20% CAGR since the financial crisis, driven by institutional reallocations from 1-2% to 15% and expanding participation from retail investors. While competition intensifies among originators targeting the lower-middle market and specialized sectors like life sciences, the sector differentiates itself through superior recovery rates via maintenance covenants and a strategic pivot toward capital protection rather than yield maximization. Looking forward, the industry faces liquidity and regulatory headwinds but expects to sustain 10-11% unlevered returns by diversifying into asset-backed finance and addressing distressed capital structures created by the current M&A slowdown.